Nowdiagnostics
NOWDiagnostics, Inc. (NOWDx) is a leader in developing over-the-counter (OTC) and point-of-care (POC) diagnostic tests, focusing on rapid, in-home testing solutions for various health conditions. The company aims to transform consumer healthcare by providing quick results in minutes, making diagnostics accessible and convenient for consumers nationwide.
Industries
Nr. of Employees
small (1-50)
Nowdiagnostics
Products
In‑home syphilis self-test (OTC, FDA-authorized)
An over-the-counter home diagnostic test for syphilis intended for consumer self-testing with results in minutes; reported to have obtained FDA authorization and been launched into national retail channels.
Home hCG pregnancy test (OTC)
An over-the-counter home diagnostic test that detects the pregnancy hormone hCG for consumer use.
In‑home syphilis self-test (OTC, FDA-authorized)
An over-the-counter home diagnostic test for syphilis intended for consumer self-testing with results in minutes; reported to have obtained FDA authorization and been launched into national retail channels.
Home hCG pregnancy test (OTC)
An over-the-counter home diagnostic test that detects the pregnancy hormone hCG for consumer use.
Services
Commercial distribution of OTC diagnostic tests
National retail and online distribution of consumer diagnostic tests through pharmacies, retail chains and e-commerce platforms.
Partnerships for public health test access
Collaborative programs with public health organizations to provide tests to at-risk populations or via health access initiatives.
Commercial distribution of OTC diagnostic tests
National retail and online distribution of consumer diagnostic tests through pharmacies, retail chains and e-commerce platforms.
Partnerships for public health test access
Collaborative programs with public health organizations to provide tests to at-risk populations or via health access initiatives.
Expertise Areas
- Over-the-counter diagnostic development
- Point-of-care diagnostics
- In‑home self-testing
- Diagnostic assay development for infectious disease and pregnancy biomarkers
Key Technologies
- Over-the-counter diagnostic platforms
- Point-of-care diagnostic devices
- In‑home self-testing workflows
- Rapid immunoassays (minutes-to-result)